Kazunari Ogawa
Papers
1
Total Citations
2
H-Index
1
About
Kazunari Ogawa is a leading urological oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly through the integration of surgical pathology and radiotherapy. His most impactful work centers on identifying predictive factors for prostate-specific antigen (PSA) recurrence after prostatectomy, a critical challenge in post-surgical management. In his landmark 2024 study, Ogawa demonstrated that the cribriform pattern—a specific histological architecture in prostate tumors—is a significant predictor of PSA recurrence in patients receiving salvage radiotherapy after radical prostatectomy. This finding provides clinicians with a powerful tool to stratify risk and tailor adjuvant treatment strategies. While his work is early in its citation trajectory, the clinical relevance of identifying cribriform pattern as a prognostic marker positions Ogawa at the forefront of personalized prostate cancer care. His research bridges the gap between pathology and radiation oncology, offering actionable insights that could reduce recurrence rates and improve long-term survival. Ogawa’s contributions are particularly valuable for urologists, radiation oncologists, and pathologists seeking evidence-based criteria to guide post-prostatectomy radiotherapy decisions.
Research Focus
Key Achievements
Top Papers
- 1